Opko Health (OPK) Q4 2023 Earnings Call Transcript
OPK earnings call for the period ending December 31, 2023.
Source: yahoo.com
Stay updated with breaking news from Renal Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OPK earnings call for the period ending December 31, 2023.
OPK earnings call for the period ending September 30, 2023.
Sodium-glucose cotransporter-2 inhibitors and sodium zirconium cyclosilicate may be paired with these kidney disease medications to reduce high serum potassium.
Anyone who has ever had a kidney stone never wants a repeat of the blinding pain that comes ...
Investigators examined the effects of vitamin D treatments, including cholecalciferol, ergocalciferol, and extended-release calcifediol in overweight patients with CKD.